No abstract available
MeSH terms
-
Adverse Drug Reaction Reporting Systems
-
Aged, 80 and over
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / adverse effects
-
Antimetabolites, Antineoplastic / metabolism*
-
Antimetabolites, Antineoplastic / pharmacokinetics
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / adverse effects
-
Antiviral Agents / metabolism*
-
Antiviral Agents / pharmacokinetics
-
Bromodeoxyuridine / administration & dosage
-
Bromodeoxyuridine / adverse effects
-
Bromodeoxyuridine / analogs & derivatives*
-
Bromodeoxyuridine / metabolism
-
Bromodeoxyuridine / pharmacokinetics
-
Capecitabine
-
Colorectal Neoplasms / complications
-
Colorectal Neoplasms / drug therapy*
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / metabolism
-
Deoxycytidine / pharmacokinetics
-
Drug Interactions
-
Drug-Related Side Effects and Adverse Reactions
-
Fatal Outcome
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Fluorouracil / analogs & derivatives*
-
Fluorouracil / metabolism
-
Fluorouracil / pharmacokinetics
-
Herpes Zoster / complications
-
Herpes Zoster / drug therapy*
-
Humans
-
Switzerland
Substances
-
Antimetabolites, Antineoplastic
-
Antiviral Agents
-
Deoxycytidine
-
brivudine
-
Capecitabine
-
Bromodeoxyuridine
-
Fluorouracil